| Henry Ford Wyandotte Hospital | |
|
2333 Biddle Ave Wyandotte MI 48192-4668 | |
| (734) 324-3516 | |
| Not Available |
| Full Name | Henry Ford Wyandotte Hospital |
|---|---|
| Speciality | Social Worker |
| Location | 2333 Biddle Ave, Wyandotte, Michigan |
| Authorized Official Name and Position | Mark Smith (SVP) |
| Authorized Official Contact | 5172056407 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Henry Ford Wyandotte Hospital 2333 Biddle Ave Wyandotte MI 48192-4668 Ph: (734) 324-3516 | Henry Ford Wyandotte Hospital 2333 Biddle Ave Wyandotte MI 48192-4668 Ph: (734) 324-3516 |
| NPI Number | 1093940272 |
|---|---|
| Provider Enumeration Date | 05/18/2009 |
| Last Update Date | 03/06/2024 |
| Certification Date | 03/06/2024 |
| Medicare PECOS PAC ID | 2264334499 |
|---|---|
| Medicare Enrollment ID | O20040316000717 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093940272 | NPI | - | NPPES |
| 800H216920 | Other | MI | BLUE CROSS BLUE SHIELD AND BLUE CARE NETWORK |
| Provider Name | Roger A Bigelow |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1548327232 PECOS PAC ID: 0143110387 Enrollment ID: I20040319000342 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Jan A Pote |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1497812994 PECOS PAC ID: 8123919263 Enrollment ID: I20040320000215 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Yassir A Attalla |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1174550974 PECOS PAC ID: 1456242247 Enrollment ID: I20040322001396 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Ammar Kanaan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1881621688 PECOS PAC ID: 0345131165 Enrollment ID: I20040322001646 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Michelle M Fundaro |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1750729281 PECOS PAC ID: 6901891076 Enrollment ID: I20040417000543 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Michael S Patterson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1891724688 PECOS PAC ID: 8921098872 Enrollment ID: I20040513001104 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | John Dubosh |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1407957384 PECOS PAC ID: 5890728950 Enrollment ID: I20050919000270 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Cheryl Lee Smith |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1073502928 PECOS PAC ID: 8527077072 Enrollment ID: I20060412000259 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Ishika Verma |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518915677 PECOS PAC ID: 7719888536 Enrollment ID: I20060619000306 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Salah A Alenzi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194796185 PECOS PAC ID: 8022185917 Enrollment ID: I20080918000205 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Kurt R Young |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1780657718 PECOS PAC ID: 6709941453 Enrollment ID: I20090213000080 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Ronald G Baker |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1588746903 PECOS PAC ID: 9537218078 Enrollment ID: I20090513000013 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Rebecca M Steele |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1093712507 PECOS PAC ID: 8022142744 Enrollment ID: I20100817001192 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Joyce E Leon |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225005002 PECOS PAC ID: 6507052255 Enrollment ID: I20101122000078 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Nancy T Sabal |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801862248 PECOS PAC ID: 2264629633 Enrollment ID: I20101210000482 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Michelle M Bauer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1750463071 PECOS PAC ID: 6800084534 Enrollment ID: I20101222000757 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Dennis R Lemanski |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1861490799 PECOS PAC ID: 3274430194 Enrollment ID: I20110331000563 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Mary Ann Skoures |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952531477 PECOS PAC ID: 8325297906 Enrollment ID: I20120926000409 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Latisha Myles |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1457699084 PECOS PAC ID: 2365688595 Enrollment ID: I20130415000024 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Annette Helina Prescod-bourne |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1841538493 PECOS PAC ID: 8123267309 Enrollment ID: I20130619000355 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Mary Ann Corneliussen |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1366884272 PECOS PAC ID: 8224272919 Enrollment ID: I20130919000324 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Steven V Crossley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770922734 PECOS PAC ID: 2860618568 Enrollment ID: I20140731002154 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Lubna Manzoor |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245512557 PECOS PAC ID: 6406170851 Enrollment ID: I20150113002331 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Justin M Adams |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1881960847 PECOS PAC ID: 5890919070 Enrollment ID: I20150706001679 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Marjan Moghaddam |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1457615247 PECOS PAC ID: 0042525495 Enrollment ID: I20150814013090 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Julio C Pinto-corrales |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1124331046 PECOS PAC ID: 1951534064 Enrollment ID: I20160727000413 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Natakki Wheatley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225423031 PECOS PAC ID: 0042581159 Enrollment ID: I20190225003100 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Abraham Markin |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1760725337 PECOS PAC ID: 6204069255 Enrollment ID: I20190816001431 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Alysse Ashkar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376071670 PECOS PAC ID: 8628349578 Enrollment ID: I20200817002147 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
| Provider Name | Hiba Jawadi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235699604 PECOS PAC ID: 9739555277 Enrollment ID: I20221025000347 |
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
News Archive
Chinese officials recorded the lowest number of new coronavirus cases in two weeks, supporting a medical adviser's projection that the outbreak may end by April. Is the coronavirus disease (COVID-19) ending soon?
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of Menerba (MF101) for menopausal hot flashes.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.
› Verified 6 days ago
Patricia Compos Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2514 Biddle Ave, Wyandotte, MI 48192 Phone: 734-558-8643 | |
Balbir Gandhi M.d.p.c Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2025 Ford Ave, Wyandotte, MI 48192 Phone: 734-281-3080 Fax: 734-281-8815 | |
Integrated Health Clinical Counseling P.l.l.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2955 Biddle Ave, Wyandotte, MI 48192 Phone: 734-720-9782 Fax: 734-571-6888 | |
Janis P Cox Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1041 1st Street, Wyandotte, MI 48192 Phone: 810-240-1139 | |
Out Of Ashes Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 135 N Riverbank St, Wyandotte, MI 48192 Phone: 810-394-1598 | |
Intuitive Growth Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Maple St Ste 104, Wyandotte, MI 48192 Phone: 734-991-3965 |